A new study by scientists at the University of Maryland School of Medicine suggests that a drug approved for treating rheumatoid arthritis (RA) reduces severe illness and death in mice exposed to the Influenza A virus. The researchers theorize that tempering the body’s immune system response to influenza infection may lessen some of the [...]
|
|||||||
|
People with Rheumatoid Arthritis (RA) have depressed immune systems and are therefore encouraged to get the annual flu vaccination. However, a recent study has found that RA patients who have taken rituximab may not get the same protection against the seasonal flu. Rituximab depletes B cells, which are responsible for producing antibodies against infections. [...] |
  
|
||||||
|
Copyright © 2012 Current Arthritis News and Research - All Rights Reserved
|
|||||||
